Attitudes and concerns regarding booster dose of COVID-19 vaccine among Egyptian patients with autoimmune and rheumatic diseases: a cross-sectional survey study.

Samar TharwatElshimaa Saad ElerakyToqa AdelMohammed Kamal NassarMarwa Saleh

Published in: Journal of pharmaceutical policy and practice (2023)

There is a low acceptability rate of booster dose of COVID-19 vaccine among Egyptian patients with ARD diseases. Public health workers and policymakers need to make sure that all ARD patients get clear messages about accepting the COVID-19 booster dose.

Keyphrases

coronavirus disease
sars cov
public health
end stage renal disease
ejection fraction
newly diagnosed
respiratory syndrome coronavirus
multiple sclerosis
patient reported outcomes
global health